DUBLIN--(BUSINESS WIRE)--The "Thrombectomy Devices Market to 2027 - Global Analysis and Forecasts by Type, Application, End User and Geography" report has been added to ResearchAndMarkets.com's ...

The rise in lifestyle-related conditions like low blood pressure, diabetes, obesity, and aging, along with the growing incidence of venous thromboembolism, cardiovascular diseases, cancer, and ...

Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics Pounce ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the ...

The UK neurovascular devices market is driven by the rising incidence of strokes, aging population, and adoption of minimally invasive treatment methods, with increased demand for thrombectomy devices ...

With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the fully mechanical Pounce™ Thrombectomy Platform can now remove thrombi or emboli ...

Ottawa, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The global thrombectomy devices market size is expected to be worth over USD 3.29 billion by 2034, increasing from USD 1.76 billion in 2025, growing at a ...

In the United States, open surgical thrombectomy was largely abandoned in the 1980s owing to the severity of complications associated with its use. [30] The one area where its use remains is in those ...

(Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world acute ...